首页 | 本学科首页   官方微博 | 高级检索  
检索        

腔内注射得力生治疗肺癌恶性胸腔积液
引用本文:袁国珍,叶书成,郝万红.腔内注射得力生治疗肺癌恶性胸腔积液[J].中国医学工程,2005,13(5):536-537,540.
作者姓名:袁国珍  叶书成  郝万红
作者单位:山东省淄博市万杰医院,山东,淄博,255213
摘    要:目的研究得力生注射液治疗肺癌恶性胸腔积液的疗效.方法对38例恶性胸腔积液患者行胸腔置管引流胸水后注入得力生注射液50~60 mL,每周2次.结果完全缓解(CR)13例,部分缓解(PR)20例,有效率(CR PR)86.8%.主要不良反应为轻度胸痛.结论得力生注射液治疗肺癌恶性胸腔积液安全有效,值得进一步研究.

关 键 词:肺癌  胸腔积液  得力生
文章编号:1672-2019(2005)05-0536-02
收稿时间:2005-03-11
修稿时间:2005年3月11日

Clinical effect study of Delisheng treatment in lung cancer patients with malignant pleural effusion
YUAN Guo-zhen,YE Shu-cheng,HAO Wan-hong.Clinical effect study of Delisheng treatment in lung cancer patients with malignant pleural effusion[J].China Medical Engineering,2005,13(5):536-537,540.
Authors:YUAN Guo-zhen  YE Shu-cheng  HAO Wan-hong
Abstract:objective To study the clinical effects of Delisheng treatment through intrapleural instillation in lung cancer patients with malignant pleural effusion. Methods] 38 cases of lung cancer patients with malignant pleural effusion were treated by intrapleural instillation Delisheng injection 50~60 mL after pleural effusion was drawn, twice per week. Results] The effective rate (CR PR) was 86.8%. The main side effect was chest pain. Conclusion] Delisheng injection treatment in lung cancer patients with malignant pleural effusion was safe and effective, It is worth further study.
Keywords:lung cancer pleural effusion Delisheng
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国医学工程》浏览原始摘要信息
点击此处可从《中国医学工程》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号